During the past decade, Lowell General Hospital conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 48 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 30 clinical trials were completed. i.e. 176.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lowell General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "SWOG Cancer Research Network" with 13 trials sponsored, "NRG Oncology" with 9 trials sponsored and "Dana-Farber Cancer Institute" with 9 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lowell General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Lowell General Hospital" with 8 trials as a collaborator, "Massachusetts General Hospital" with 6 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 5 trials as a collaborator. Other collaborators include 106 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Lowell General Hospital" are "Breast Cancer" (22 trials), "Prostate Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Lowell General Hospital" in a lesser frequency.

Most popular intervention types in "Lowell General Hospital" are "Drug" (79 trials), "Other" (54 trials), "Radiation" (32 trials), "Biological" (28 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (19 trials), "Paclitaxel" (16 trials), "Carboplatin" (14 trials) and "Computed Tomography" (10 trials). Other intervention names were less common.

The vast majority of trials in "Lowell General Hospital" are 70 trials for "All" genders, 30 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Lowell General Hospital". undefined are not yet recruiting, 15 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Lowell General Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lowell General Hospital, 0 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".